Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Y Wu

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Urology|April 1, 2019
Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage RadiotherapyLauren Boreta, Adam J Gadzinski, Susan Y Wu, et al.
Leukemia & Lymphoma|July 7, 2024
Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer centerJared R Zhang, Susan Y Wu, Preetesh Jain, et al.
Urology|December 24, 2018
Impact of Staging <sup>68</sup>Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate CancerSusan Y Wu, Lauren Boreta, Katsuto Shinohara, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2023
Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation TherapyPenny Fang, Chelsea C Pinnix, Susan Y Wu, et al.
Practical Radiation Oncology|July 10, 2026
Safety of concurrent radiation therapy with the antibody-drug conjugate polatuzumab vedotin in relapsed or refractory aggressive B-cell lymphomasSophie T Melancon, Ethan B Wang, Penny Q Fang, et al.
Advances in Radiation Oncology|July 14, 2023
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of LymphomaSusan Y Wu, Penny Q Fang, Ethan B Wang, et al.
JAMA Network Open|September 30, 2020
Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical TrialSusan Y Wu, Ann A Lazar, Matthew A Gubens, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 2026
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell LymphomaSavita V Dandapani, Sairah Ahmed, Timothy Robinson, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Urology|April 1, 2019
Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage RadiotherapyLauren Boreta, Adam J Gadzinski, Susan Y Wu, et al.
Leukemia & Lymphoma|July 7, 2024
Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer centerJared R Zhang, Susan Y Wu, Preetesh Jain, et al.
Urology|December 24, 2018
Impact of Staging <sup>68</sup>Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate CancerSusan Y Wu, Lauren Boreta, Katsuto Shinohara, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2023
Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation TherapyPenny Fang, Chelsea C Pinnix, Susan Y Wu, et al.
Practical Radiation Oncology|July 10, 2026
Safety of concurrent radiation therapy with the antibody-drug conjugate polatuzumab vedotin in relapsed or refractory aggressive B-cell lymphomasSophie T Melancon, Ethan B Wang, Penny Q Fang, et al.
Advances in Radiation Oncology|July 14, 2023
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of LymphomaSusan Y Wu, Penny Q Fang, Ethan B Wang, et al.
JAMA Network Open|September 30, 2020
Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical TrialSusan Y Wu, Ann A Lazar, Matthew A Gubens, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 2026
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell LymphomaSavita V Dandapani, Sairah Ahmed, Timothy Robinson, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Pageof 4